Corcept Therapeutics Market Sentiment

Corcept Therapeutics Inc

CORTNASDAQ

Trade with Public

$112.10

1.941.76%

Dern. MÀJ: Oct 20, 4:37 AM

$112.71

2.552.31%

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

Corcept Therapeutics Market Sentiment

Market sentiment signals for Corcept Therapeutics (CORT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 10.2% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

6 analysts

Options Flow (P/C)

—

Avg Consensus PT

$127

+12.8%

Highest Price Target

$165

+46.4%

Piper Sandler

Lowest Price Target

$50

-55.6%

Wolfe Research

Short Interest

10.2%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 18, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	+46.4%	$165 → $165	Maintained	Buy
Jul 30, 2026	Piper Sandler	David Amsellem—	+46.4%	$88 → $165	Maintained	Overweight
Jul 30, 2026	Canaccord Genuity	Edward Nash—	+42.8%	$150 → $161	Maintained	Buy
Jul 30, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	+46.4%	$95 → $165	Maintained	Buy
Jul 29, 2026	Canaccord Genuity	Edward Nash—	+33.1%	$135 → $150	Maintained	Buy
Jul 27, 2026	Wolfe Research	Kalpit Patel—	-55.6%	$50	Downgrade	Peer Perform→Underperform
May 28, 2026	Canaccord Genuity	Edward Nash—	+19.8%	$110 → $135	Maintained	Buy
May 28, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-15.7%	$75 → $95	Maintained	Buy
May 13, 2026	UBS	Ashwani Verma—	-36.1%	$44 → $72	Upgrade	Neutral→Buy
May 4, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-33.5%	$60 → $75	Maintained	Buy
May 1, 2026	Piper Sandler	David Amsellem—	-21.9%	$73 → $88	Maintained	Overweight
Mar 26, 2026	Canaccord Genuity	Edward Nash—	-2.4%	$100 → $110	Maintained	Buy
Mar 26, 2026	Wolfe Research	Kalpit Patel—	—	—	Upgrade	Underperform→Peer Perform
Mar 25, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-46.8%	$67 → $60	Maintained	Buy
Feb 25, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-46.8%	$67 → $60	Maintained	Buy
Feb 20, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-40.6%	$105 → $67	Maintained	Buy
Jan 23, 2026	Canaccord Genuity	Edward Nash—	-11.3%	$99 → $100	Maintained	Buy
Jan 23, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-6.8%	$90 → $105	Maintained	Buy
Jan 2, 2026	Canaccord Genuity	Edward Nash—	-12.2%	$140 → $99	Maintained	Buy
Jan 2, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-20.1%	$145 → $90	Maintained	Buy
Dec 16, 2025	UBS	Ashwani Verma—	-15.7%	$95	Initiate	Neutral
Nov 25, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+28.6%	$145 → $145	Maintained	Buy
Nov 18, 2025	Wolfe Research	Kalpit Patel—	—	—	Initiate	Peer Perform
Oct 20, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+28.6%	$145 → $145	Maintained	Buy
Oct 10, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+28.6%	$145 → $145	Maintained	Buy